Northwestern Mutual Investment Management Company, LLC Biogen Inc. Transaction History

Northwestern Mutual Investment Management Company, LLC

$3.84 Billion
Q2 2024

A detailed history of Northwestern Mutual Investment Management Company, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Northwestern Mutual Investment Management Company, LLC holds 4,634 shares of BIIB stock, worth $805,342. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,634

Previous 4,598 0.78%

Holding current value

$805,342

Previous $991,000 8.38%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$190.52 - $236.72 $6,858 - $8,521	36 Added 0.78%	4,634 $1.07 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $2,544 - $3,212	12 Added 0.26%	4,598 $991,000
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $3,338 - $4,019	15 Added 0.33%	4,586 $1.19 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $1,519 - $1,715	6 Added 0.13%	4,571 $1.17 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $10,734 - $12,404	39 Added 0.86%	4,565 $1.3 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $3,591 - $4,092	14 Added 0.31%	4,526 $1.26 Million
Q4 2022 Feb 21, 2023	SELL	$252.44 - $306.72 $221,389 - $268,993	-877 Reduced 16.27%	4,512 $1.25 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $90,336 - $124,565	-464 Reduced 7.93%	5,389 $1.44 Million
Q2 2022 Aug 04, 2022	SELL	$187.54 - $223.02 $121,525 - $144,516	-648 Reduced 9.97%	5,853 $1.19 Million
Q1 2022 May 09, 2022	SELL	$193.77 - $244.14 $152,109 - $191,649	-785 Reduced 10.77%	6,501 $1.37 Million
Q4 2021 Feb 03, 2022	SELL	$223.92 - $287.77 $42,768 - $54,964	-191 Reduced 2.55%	7,286 $1.75 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $181,396 - $236,561	641 Added 9.38%	7,477 $2.12 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $17,871 - $28,614	-69 Reduced 1.0%	6,836 $2.37 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $373,900 - $438,045	-1,539 Reduced 18.23%	6,905 $1.93 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $123,091 - $185,283	-521 Reduced 5.81%	8,444 $2.07 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $114,327 - $151,407	-442 Reduced 4.7%	8,965 $2.4 Million
Q1 2020 May 08, 2020	BUY	$268.85 - $341.04 $644,702 - $817,813	2,398 Added 34.21%	9,407 $2.98 Million
Q4 2019 Feb 07, 2020	SELL	$220.06 - $304.07 $3,300 - $4,561	-15 Reduced 0.21%	7,009 $2.08 Million
Q3 2019 Nov 06, 2019	SELL	$217.44 - $243.88 $71,972 - $80,724	-331 Reduced 4.5%	7,024 $1.64 Million
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $4.94 Million - $5.45 Million	-22,536 Reduced 75.39%	7,355 $1.72 Million
Q1 2019 May 10, 2019	SELL	$216.71 - $338.96 $102,287 - $159,989	-472 Reduced 1.55%	29,891 $7.07 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $1.36 Million - $1.72 Million	-4,888 Reduced 13.87%	30,363 $9.14 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $1.51 Million - $1.98 Million	-5,157 Reduced 12.76%	35,251 $12.5 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $489,030 - $582,822	1,899 Added 4.93%	40,408 $11.7 Million
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $2.41 Million - $3.4 Million	-9,248 Reduced 19.36%	38,509 $10.5 Million
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $108,596 - $121,636	353 Added 0.74%	47,757 $15.2 Million
Q3 2017 Nov 13, 2017	SELL	$281.15 - $329.69 $454,057 - $532,449	-1,615 Reduced 3.29%	47,404 $14.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	40,663 Added 486.63%	49,019 $13.3 Million
Q2 2017 Aug 09, 2017	BUY	N/A	8,356	8,356 $2.02 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Investment Management Company, LLC with notifications on news.

Account

Northwestern Mutual Investment Management Company, LLC Biogen Inc. Transaction History